✦ LIBER ✦

Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin

✍ Scribed by D. P. Kelsen; M. Bains; B. Hilaris; R. Chapman; P. McCormack; J. Alexander; S. Hopfan; N. Martini

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 440 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820315)49:6<1174::aid-cncr2820490618>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of BELD combination chemotherapy

The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma

✍ David W. Young; Rosemary S. Lever; JOHN S. C. English; Rona M. Mackie 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

Fluorouracil (F), adriamycin (A), and ci

Fluorouracil (F), adriamycin (A), and cisplatin (P) (FAP): Combination chemotherapy of advanced esophageal carcinoma

✍ Dr. Christian Gisselbrecht; Fabien Calvo; Laurent Mignot; Eric Pujade; Michel Bo 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Twenty-one patients with advanced epidermoid carcinoma of the esophagus were treated with a combination of 5-fluorouracil (F) 600 mg/m2 day 1 and day 8; Adriamycin (A) 30 mg/m2 day 1; and cisplatin (P) 75 mg/m2 day 1 (FAP) with hydration and mannitol-induced diuresis. Each course was repeated every

Successful treatment of metastatic thymi

Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy

✍ Robert W. Carlson; Ronald F. Dorfman; Branimir I. Sikic 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 2 views

Multidrug chemotherapy using bleomycin,

Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer

✍ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Cyclophosphamide, doxorubicin, and cispl

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

✍ Arnon I. Dreyfuss; John R. Clark; Barbara G. Fallon; Marshall R. Posner; Charles 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.